<DOC>
	<DOC>NCT00343343</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this investigation is to explore the safety of a 4 mm needle compared to a 6 mm needle when injected in children and lean adults with diabetes.</brief_summary>
	<brief_title>Comparison of NovoFine® Needles (4 mm vs. 6 mm)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Children Type 1 diabetes Insulin treatment for more than ½ year BMI lesser than or equal to 19 kg/m2 Last HbA1c taken within the last year lesser than 10.5% Girls: only prepubertal Boys: both pre pubertal and pubertal. Adults Type 1 and 2 diabetes Insulin treatment for more than ½ year BMI lesser than or equal to 23 kg/m2 Last HbA1c taken within the last year lesser than 10.5% Known or suspected allergy to trial product(s) or related products. Pregnant, breastfeeding or the intention of becoming pregnant or not using adequate contraceptive measures (including countryspecific adequate measures, if any). Skin disease at abdomen and/or thigh</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>